BioNeutral Group, Inc. Retains Chertoff Group as Strategic Advisors

NEWARK, N.J.--(BUSINESS WIRE)--BioNeutral Group, Inc. (“BioNeutral”) (OTCBB: BONU), a chemical technology-based Life Science company announced today that it has retained the Chertoff Group to provide strategic advisory services for BioNeutral’s proprietary chemical technology, and to make preliminary recommendations as to its potential use in commercial and government health, defense and bio security markets in the United States.

“We are excited to engage former Secretary Chertoff and his firm to assist us in our endeavors; presenting our proprietary technology to the various markets including health, defense and bio security”

The Chertoff Group (www.chertoffgroup.com) is based in Washington, DC and is led by former Secretary of Homeland Security Michael Chertoff. The Chertoff Group is a security and risk management advisory firm that counsels corporate and government clients addressing threats related to terrorism, fraud, cyber security, border protection and supply chain security. The firm provides business leaders and local government officials with the same kind of high-level, strategic thinking and diligent execution that have kept the American homeland and its people safe since 9/11.

"We are excited to engage former Secretary Chertoff and his firm to assist us in our endeavors; presenting our proprietary technology to the various markets including health, defense and bio security," comments Stephen J. Browand, President and CEO of BioNeutral Group, Inc. "It is a privilege to have such an elite group represent our Company and we are confident that they will play a significant role in the successful strategic introduction of our life saving technology."

About BioNeutral Group, Inc.

Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene™ and Ogiene™, which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral’s proprietary platform technology has been proven effective in surface, water and airborne applications.

More information about the Company may be found at www.bioneutralgroup.com

Forward-Looking Statements

BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene™ and are not yet available for sale in the United States.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of BioNeutral Group can be found in the filings of BioNeutral Group with the U.S. Securities and Exchange Commission.

www.corporateevolutions.com